Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, In...

FDA Recall #D-0590-2025 — Class II — August 4, 2025

Recall #D-0590-2025 Date: August 4, 2025 Classification: Class II Status: Ongoing

Product Description

Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.

Reason for Recall

Lack of Assurance of Sterility.

Recalling Firm

PFIZER INC — New York, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

49,620 vials

Distribution

U.S. Nationwide

Code Information

Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated